Dr. Rami Manochakian, MD

Dr. Manochakian practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Manochakian's NPI, 1619112034, was assigned on December 15, 2008. Dr. Manochakian graduated from University of Aleppo Faculty of Medicine in 2004. Dr. Manochakian holds Florida license ME129391.

Dr. Manochakian's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Manochakian's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Manochakian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manochakian practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Manochakian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Manochakian is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Manochakian's licenses on file in 3 states: Florida, Tennessee and Ohio.

Dmand AI lists breast cancer, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Manochakian treats.

CMS data shows 79,332 Medicare services from Dr. Manochakian across 55 procedure codes in 2024, for 767 Medicare patients. Medicare paid $1,299,833 for them. Every service was in an office.

CMS counts 767 Medicare patients who saw Dr. Manochakian in 2024. The largest group is 65 to 74, with 377 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manochakian's median patient age at 66, with 51% women.

In 2024, Dr. Manochakian wrote 123 Medicare Part D claims for 31 patients. 39% of them were for generic drugs. CMS names the drug for 55 of them, across 2 drugs with 11 or more claims each, at $941,768 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Dr. Manochakian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manochakian as offering telehealth.

Dmand AI links 59 papers to Dr. Manochakian, published from 2014 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Medical Oncology. Dr. Manochakian has published most often in Front Oncol. Dr. Manochakian's most frequent co-authors are Yanyan Lou, MD, Yujie Zhao, MD, PhD and Sikander Ailawadhi, MD.

CMS Open Payments shows 67 general payments to Dr. Manochakian from 11 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 74% of the total. AstraZeneca Pharmaceuticals LP paid the most, $18,059.

Dr. Manochakian graduated from University of Aleppo Faculty of Medicine in 2004.

Dr. Manochakian is in network with 7 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.